The Federal Institute for Drugs and Medical Devices (BfArM) refers to counterfeits of the medicinal product Omnitrope® 15 mg / 1.5 ml solution for injection by the company Sandoz reported in France, Denmark and Mexico. The medicinal product normally contains the active substance somatropin and is a growth hormone used for the treatment of growth hormone deficiency.

risk information - full text (available in German only)